T1	Participants 89 129	children with acute lymphocytic leukemia
T2	Participants 166 230	Eighty-seven children with central nervous system (CNS) leukemia
T3	Participants 1625 1896	The children on both regimens were comparable for sex, race, age at initial ALL diagnosis, time from ALL diagnosis to first episode of CNS leukemia, systemic therapy both before and after CNS relapse, and number of blasts in the spinal fluid at diagnosis of CNS leukemia.
